Moderate Risk of CVD Completed Phase 3 Trials for Acetylsalicylic acid (DB00945)

IndicationStatusPhase
DBCOND0038082 (Moderate Risk of CVD)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00501059A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular DiseasePrevention